Surgical Endoscopy

, 25:1753 | Cite as

Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer

  • Roger W. Motson
  • J. S. Khan
  • T. H. A. Arulampalam
  • R. C. T. Austin
  • N. Lacey
  • B. Sizer



Laparoscopic total mesorectal excision (TME) of locally advanced rectal cancer after long-course chemoradiotherapy (LCRT) is surgically and oncologically challenging. We have assessed the feasibility, timing, and short-term oncological outcome of laparoscopic TME after LCRT.


Between 2004 and 2006, 30 patients were selected for LCRT based on clinical examination and MRI. Patients received 3/4 field radiotherapy, 45–50.4 Gy in 25–28 fractions during 5 weeks with either 5-fluorouracil or Uftoral. Clinical assessments were made 4 weeks after completion of radiotherapy and then 2 weekly with sequential 4 weekly MRI, to individualize the timing of surgery at maximal response. Laparoscopic TME was performed using a standard technique.


Thirty patients received LCRT and 26 patients (21 men; median age, 63 years) underwent laparoscopic TME at 11 weeks (median) after LCRT. Median operating time was 270 min. Sixteen patients had LAR and ten had APR. There were three conversions. Three patients developed anastomotic leak (18.7%): one was managed conservatively and one patient died of septicemia. Morbidity was seen in 19% of patients. There were 25 (96%) R0 resections with a complete response in 5 (19%) cases and microscopic tumor in lakes of mucin (Tmic) in another 6 (23%). Two patients (7.6%) developed local recurrence (median follow up, 34 months). The median time interval between radiotherapy and surgery was 11 (range, 7–13) weeks, which was based on serial MRI scans after LCRT.


Laparoscopic TME after LCRT is feasible and safe both oncologically and surgically. Serial MRI helps to determine the optimum timing of surgery.


Laparoscopic total mesorectal excision Locally advanced rectal cancer Long-course chemoradiotherapy 



The authors wish to acknowledge the support of Mrs Jane Bradley-Hendricks and Professor John Norton in writing this manuscript.


R. W. Motson, J. S. Khan, T. H. A. Arulampalam, R. C. T Austin, N. Lacey, and B. Sizer have no conflicts of interest or financial ties to disclose.


  1. 1.
    Daniels I, Fisher S, Heals R, Moran B (2007) Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis 9(4):290–301PubMedCrossRefGoogle Scholar
  2. 2.
    Sauer R, Becker H, Hohenberger W et al (2004) German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRefGoogle Scholar
  3. 3.
    Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921. J Clin Oncol 23(24):5620–5627PubMedCrossRefGoogle Scholar
  4. 4.
    Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro U Jr, Silva E, Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues JA (2005) Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 9(1):90–99PubMedCrossRefGoogle Scholar
  5. 5.
    Habr-Gama A (2006) Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 8(Suppl 3):21–24PubMedCrossRefGoogle Scholar
  6. 6.
    Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J (1999) Tumor down staging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the MD Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44(5):1027–1038PubMedCrossRefGoogle Scholar
  7. 7.
    Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J (1992) Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 10(1):79–84PubMedGoogle Scholar
  8. 8.
    Kapiteijn E, Marijnen C, Nagtegaal I, Putter H et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMedCrossRefGoogle Scholar
  9. 9.
    Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G (1994) Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 30:169–175PubMedGoogle Scholar
  10. 10.
    Rodríguez-Ramírez SE, Uribe A, Ruiz-García EB, Labastida S, Luna-Pérez P (2006) Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer. Rev Invest Clin 58(3):204–210PubMedGoogle Scholar
  11. 11.
    Marijnen CA, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW, Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20(3):817–825PubMedCrossRefGoogle Scholar
  12. 12.
    Klessen C, Rogalla P, Taupitz M (2007) Local staging of rectal cancer: the current role of MRI. Eur Radiol 17(2):379–389PubMedCrossRefGoogle Scholar
  13. 13.
    Brown G, Richards C, Newcombe R, Dallimore N, Radcliffe A, Carey D, Bourne M, Williams G (1999) Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 211:215–222PubMedGoogle Scholar
  14. 14.
    Beets-Tan R, Beets G, Vliegen R, Kessels A, Boven Van, De Bruine A, von Meyenfeldt M, Baeten C, van Engelshoven J (2001) Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet 357(9255):497–504PubMedCrossRefGoogle Scholar
  15. 15.
    MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333(7572):779CrossRefGoogle Scholar
  16. 16.
    Habr-Gama A, Perez R, Proscurshim I, Campos F, Nadalin W, Kiss D, Gama-Rodrigues J et al (2006) Patterns of failure and survival for non-operative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 10(10):1319–1328PubMedCrossRefGoogle Scholar
  17. 17.
    Parvais A, Lawes D, Gilani S, Arulampalam T, Austin R, Motson R (2006) Outcome following laparoscopic rectal resections for cancer: experience with 125 consecutive cases. Surg Endosc 20(Suppl 1):S253Google Scholar
  18. 18.
    Jayne DG, Guillou P, Thorpe H, Quirke P et al (2007) Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25(21):3061–3068PubMedCrossRefGoogle Scholar
  19. 19.
    Lacy AM, Garcia-Valdecasas JC, Delgado S et al (2002) Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer; a RCT. Lancet 359(9325):2224–2229PubMedCrossRefGoogle Scholar
  20. 20.
    Morino M, Parini U, Giraudo G, Salval M, Brachet Contul R, Garrone C (2003) Laparoscopic total mesorectal excision: a consecutive series of 100 patients. Ann Surg 237:335–342PubMedGoogle Scholar
  21. 21.
    Arulampalam T, Austin R, Motson R (2005) MRC CLASICC trial. Lancet 366(9487):712PubMedCrossRefGoogle Scholar
  22. 22.
    Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, Nygren J, Hausel J, Soop M, Andersen J, Kehlet H (2005) Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 24(3):466–477PubMedCrossRefGoogle Scholar
  23. 23.
    King PM, Blazeby JM, Ewings P, Franks PJ, Longman R, Kendrick A, Kipling RM, Kennedy RH (2006) Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme. Br J Surg 93(3):300–308PubMedCrossRefGoogle Scholar
  24. 24.
    Motson RW (1994) Direct puncture technique for laparoscopy. Ann R Coll Surg Engl 76(5):346–347PubMedGoogle Scholar
  25. 25.
    Nilsson P, Svensson C, Goldman S, Glimelius (2002) Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 89(11):1425–1429PubMedCrossRefGoogle Scholar
  26. 26.
    Butler CE, Gündeslioglu AO, Rodriguez-Bigas MA (2008) Outcomes of immediate vertical rectus abdominis myocutaneous flap reconstruction for irradiated abdominoperineal resection defects. J Am Coll Surg 206(4):694–703PubMedCrossRefGoogle Scholar
  27. 27.
    Gerard JP, Romestaing P, Ardiet JM, Mornex F (1998) Endocavitary radiation therapy. Semin Radiat Oncol 8:13–23PubMedCrossRefGoogle Scholar
  28. 28.
    Habr-Gama A, de Souza PM, Ribeiro U Jr, Nadalin W, Gansl R, Sousa AH Jr, Campos FG, Gama-Rodrigues J (1998) Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41(9):1087–1096PubMedCrossRefGoogle Scholar
  29. 29.
    Sizer B, Arulampalam T, Austin R, Basu D, Lacey N, Menzies D, Motson R (2007) Individualizing the interval between neoadjuvant chemoradiation with uracil-tegafur (UFT) and total mesorectal excision in magnetic resonance imaging defined poor risk rectal cancer. J Clin Oncol 25(18S):14557Google Scholar
  30. 30.
    Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG (2002) Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Dis Colon Rectum 45(10):1349–1358PubMedCrossRefGoogle Scholar
  31. 31.
    Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355–364PubMedCrossRefGoogle Scholar
  32. 32.
    Mercury Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 333:779–881CrossRefGoogle Scholar
  33. 33.
    Sizer BF, Arulampalam T, Austin R, Lacey N, Menzies D, Motson R (2006) MRI in predicting curative resection of rectal cancer: defining a “window of opportunity” for laparoscopic surgery. BMJ 333(7572):808–809PubMedCrossRefGoogle Scholar
  34. 34.
    Johnston DF, Lawrence KM, Sizer BF, Arulampalam TH, Motson RW, Dove E, Lacey N (2009) Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy. Br J Radiol 82(976):332–336PubMedCrossRefGoogle Scholar
  35. 35.
    Miyajima N, Fukunaga M, Hasegawa H et al (2009) Results of a multicentre study of 1,057 cases of rectal cancer treated by laparoscopic surgery. Surg Endosc 129:674–680Google Scholar
  36. 36.
    Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J (2004) Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc 18:281–289PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Roger W. Motson
    • 1
  • J. S. Khan
    • 1
  • T. H. A. Arulampalam
    • 1
  • R. C. T. Austin
    • 1
  • N. Lacey
    • 1
  • B. Sizer
    • 1
  1. 1.The ICENI Centre, Colchester General HospitalColchesterUK

Personalised recommendations